Specifically, the authors showed that TIM-3 was predominantly expressed by TADCs and interacted with HMGB1, suppressing nucleic acid-mediated activation (preventing localisation in endosomal vesicles) of an effective anti-tumour immune response. This evidence concerns the gene HAVCR2 and neoplasm.